Zobrazeno 1 - 10
of 347
pro vyhledávání: '"gastro-oesophageal junction"'
Autor:
Francisco Cezar Aquino de Moraes, Eric Pasqualotto, Matheus Pedrotti Chavez, Rafael Oliva Morgado Ferreira, Tiago Biachi De Castria, Rommel Mario Rodríguez Burbano
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background The benefit of adding Zolbetuximab to the treatment in patients with Claudin-18 isoform 2 (CLDN18.2)-positive, human epidermal growth factor receptor 2-negative, locally advanced unresectable or metastatic gastric or gastro-oesoph
Externí odkaz:
https://doaj.org/article/d93b0e9e52ae426da9d99b3ed83fbc4f
Autor:
Zhanpeng Liang, Liwen Liu, Wenxia Li, Huiqin Lai, Luzhen Li, Jiaming Wu, Huatang Zhang, Cantu Fang
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
ObjectiveZolbetuximab is a “first-in-class” chimeric lgG1 monoclonal antibody targeting Claudin18.2 (CLDN 18.2). In recent years, several important trials have been published showing that zolbetuximab is associated with improved prognosis in pati
Externí odkaz:
https://doaj.org/article/ee5f0b5ec11745d7ad4fb1eff4ccdd47
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Minimal Access Surgery, Vol 18, Iss 3, Pp 459-462 (2022)
A 63-year-old male presented to us with upper abdominal pain and odynophagia for 3 months. Contrast-enhanced computed tomography of the abdomen revealed hiatus hernia with ulceroproliferative growth involving the gastro-oesophageal (GE) junction and
Externí odkaz:
https://doaj.org/article/d0e8417452764f19ada2cf26ef8a9416
Autor:
Elisa Giommoni, Daniele Lavacchi, Giuseppe Tirino, Lorenzo Fornaro, Francesco Iachetta, Carmelo Pozzo, Maria Antonietta Satolli, Andrea Spallanzani, Marco Puzzoni, Silvia Stragliotto, Michele Sisani, Vincenzo Formica, Filippo Giovanardi, Antonia Strippoli, Michele Prisciandaro, Samantha Di Donato, Luca Pompella, Irene Pecora, Alessandra Romagnani, Sara Fancelli, Marco Brugia, Serena Pillozzi, Ferdinando De Vita, Lorenzo Antonuzzo
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background Perioperative FLOT (5-fluorouracil, oxaliplatin and docetaxel) has recently become the gold standard treatment for fit patients with operable gastric (GC) or gastroesophageal (GEJ) adenocarcinoma, getting a 5-year overall survival
Externí odkaz:
https://doaj.org/article/4e1e9985336f400fb0fee581324d30e7
Publikováno v:
Journal of Minimal Access Surgery, Vol 17, Iss 2, Pp 236-240 (2021)
Background: Locally advanced long Siewert type II tumor requires total gastrectomy and D2 lymphadenectomy with distal esophagectomy and mediastinal lymphadenectomy for curative resection. In this scenario, a laparoscopic transhiatal approach is not f
Externí odkaz:
https://doaj.org/article/bff94437b3eb499d945fecd2f15821b2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Meike Kohlruss, Bianca Grosser, Marie Krenauer, Julia Slotta‐Huspenina, Moritz Jesinghaus, Susanne Blank, Alexander Novotny, Magdalena Reiche, Thomas Schmidt, Liridona Ismani, Alexander Hapfelmeier, Daniel Mathias, Petra Meyer, Matthias M Gaida, Lukas Bauer, Katja Ott, Wilko Weichert, Gisela Keller
Publikováno v:
The Journal of Pathology: Clinical Research, Vol 5, Iss 4, Pp 227-239 (2019)
Abstract Epstein–Barr virus positivity (EBV(+)) and high‐microsatellite instability (MSI‐H) have been identified as molecular subgroups in gastric carcinoma. The aim of our study was to determine the prognostic and predictive relevance of these
Externí odkaz:
https://doaj.org/article/1459b21410b843e08844499d9774926e
Autor:
Camille Evrard, Thomas Aparicio, Emilie Soularue, Karine Le Malicot, Jérôme Desramé, Damien Botsen, Farid El Hajbi, Daniel Gonzalez, Come Lepage, Olivier Bouché, David Tougeron, on behalf of the DURIGAST—PRODIGE 59 Investigators/Collaborators
Publikováno v:
Biomedicines, Vol 10, Iss 5, p 1211 (2022)
Efficacy of immune checkpoint inhibitors (ICI) as monotherapy in 2nd line treatment for gastric or gastro-oesophageal junction (GEJ) adenocarcinoma is low, with no evaluation of efficacy and safety of ICI combined with chemotherapy. The DURIGAST PROD
Externí odkaz:
https://doaj.org/article/e5f33636db76484d82559bf48a274df7
Autor:
Jeff Bull, Christos S. Karapetis, Amitesh Roy, Sarah K. Thompson, Timothy J. Price, Caroline Connell, Nimit Singhal, M. Nazim Abbas, David I. Watson, Mary Barnes, Tim Bright
Publikováno v:
ANZ Journal of Surgery. 91:2675-2682
BACKGROUND A single state-wide upper gastrointestinal (GI) cancer video-linked multidisciplinary team (MDT) meeting guides management and evidence-based care for all newly diagnosed upper GI cancer patients in South Australia. This study determined t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0de06f9c4318f0c864e1bcb2841d38fa
https://doi.org/10.1111/ans.17249
https://doi.org/10.1111/ans.17249